Reports
RECENT NEWS
Unmasking the Real Cost Drivers in U.S. Healthcare: A Critical Examination of Hospital Pricing and Policy Reform
From 2000 to 2020, the U.S. saw more than 1,600 hospital mergers. These consolidations have led to decreased competition,... Read more
The biggest challenge facing the FDA’s new Rare Disease Innovation Hub
Differing philosophies within and outside of government could doom the hub... Read more
Countries Not Paying Their Fair Share of the Cost of Biopharmaceutical Innovation - What Can the US Do to Change That?
The principal reason for the disparity in biopharmaceutical pricing is that governments in other developed countries use ... Read more